Literature DB >> 11421295

Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL.

M Heizmann1, P Itin, M Wernli, L Borradori, M J Bargetzi.   

Abstract

Paraneoplastic pemphigus is a severe mucocutaneous disease associated in most cases with B-cell lymphoproliferative disorders. Independent of the course of the underlying malignancy, this autoimmune skin disease is resistant to any treatment in most cases and may lead to death by infectious complications. We observed a patient with recovery of paraneoplastic pemphigus associated with follicular non-Hodgkin's-lymphoma after therapy with rituximab. In addition, we reviewed the literature and analyzed the few cases with comparable outcome with other treatment modalities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11421295     DOI: 10.1002/1096-8652(200102)66:2<142::AID-AJH1032>3.0.CO;2-0

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  16 in total

Review 1.  [Pemphigus. Model disease for targeted therapy].

Authors:  R Eming
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

Review 2.  Pemphigus.

Authors:  Michael Kasperkiewicz; Christoph T Ellebrecht; Hayato Takahashi; Jun Yamagami; Detlef Zillikens; Aimee S Payne; Masayuki Amagai
Journal:  Nat Rev Dis Primers       Date:  2017-05-11       Impact factor: 52.329

Review 3.  [Paraneoplastic autoimmune dermatoses].

Authors:  D Didona; M Hertl
Journal:  Hautarzt       Date:  2021-03-01       Impact factor: 0.751

Review 4.  Current and Innovated Managements for Autoimmune Bullous Skin Disorders: An Overview.

Authors:  Kuan-Yu Chu; Hsin-Su Yu; Sebastian Yu
Journal:  J Clin Med       Date:  2022-06-19       Impact factor: 4.964

5.  The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human.

Authors:  Isabelle Schepens; Fabienne Jaunin; Nadja Begre; Ursula Läderach; Katrin Marcus; Takashi Hashimoto; Bertrand Favre; Luca Borradori
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

6.  A Case of Paraneoplastic Pemphigus as a Preceding Manifestation of Underlying Follicular Lymphoma Treated with R-CHOP.

Authors:  Minsu Kim; Ji Yun Lee; Soo-Chan Kim; Jung-Im Na
Journal:  Ann Dermatol       Date:  2021-05-04       Impact factor: 1.444

7.  Therapy of autoimmune bullous diseases.

Authors:  Diya F Mutasim
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

Review 8.  Paraneoplastic pemphigus: a short review.

Authors:  Marta Wieczorek; Annette Czernik
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-09-23

Review 9.  Biologics in dermatology: an integrated review.

Authors:  Virendra N Sehgal; Deepika Pandhi; Ananta Khurana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

10.  A Comparative Study to Evaluate the Efficacy and Cost of Rituximab versus Dexamethasone Cyclophosphamide Pulse in Patients of Pemphigus Vulgaris.

Authors:  Sudip Das; Komal Agarwal; Sonal Singh; Deepika Halder; Sujata Sinha; Abhishek De
Journal:  Indian J Dermatol       Date:  2021 Mar-Apr       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.